| surviveCANCER
Foundation |
| ||||
| .: resources | |||||
|
As we are in the process of establishing a 501 (c)(3) non-profit, public charity based upon giving away counseling and support for cancer victims and their families, we are not in the business of selling books. We are providing a link to Amazon.com to purchase new or used copies of what we use for references. The prices you will pay for what you purchase are the same as purchasing directly from Amazon.com; you will not pay more. Thanks for supporting us in our effort to educate others. .: resources.reference materialsThis is a list of book and magazine publications I have read and collected by subject. Some of these, such as the biblical references I have had for many years. Newer topics such as dealing with cancer, the immune system, dietary changes, etc… are very recent to my readings. All of them represent a good place to start your research. As time goes on, I will add other things here that broach subjects not covered. Note: My primary cancer research is on what I have (kidney cancer). I will attempt to put things of a general nature in here so that everyone can benefit from my research. Not all cancers are alike other than some basic concepts. Many are unique on to themselves and what works successfully for one thing, might not work well for others. Example: Kidney cancer does not respond (5—7% success rate) to chemotherapy or radiation. Hence, I have spent little time researching these items. Biblical As we are in the process of establishing a 501 (c)(3) non-profit, public charity based upon giving away counseling and support for cancer victims and their families, we are not in the business of selling books. We are providing a link to Amazon.com to purchase new or used copies of what we use for references. The prices you will pay for what you purchase are the same as purchasing directly from Amazon.com; you will not pay more. Thanks for supporting us in our effort to educate others. Bruce and Beverly. Beginnings in Bible Archeology, Vos, H.F. The Bible
The Dawn of World Redemption, Sauer, E. William
Genesis and Evolution, DeHaan, M.R.
The Genesis Record: A Scientific and Devotional Commentary, Morris
Exodus, Jensen, I.L.
Hammond’s Atlas of the Bible Lands, Frank, H.T.
Lectures on the Book of Revelation, Ironside, H.A.
Meditation on Ecclesiastes, Jennings, F.C.
The Minor Prophets, Feinberg, C.L.
The Minor Prophets, Ironside, H.A.
The Parables of our Lord
Pentecost, J.D. The Proverbs, Kidner, D. The Revelation of Jesus Christ, Walvoord, J.F. Synthetic Bible
Studies, Gray, J.M.; Through the Bible Commentary, McGee, J.V. The Unfolding Drama of Redemption, Scroggie, W.G. The Unfolding Message of the Bible,
Morgan, G.C. Unger’s Bible Handbook,
Unger, M.F. Unger’s Commentary on the Old Testament,
Unger, M.F. Shinkai, S., Konishi, M., Shepard, R. J. (1998). “Aging and the Immune Response to Exercise.” Canadian Journal of Physiological Pharmacology, 76:5, 562-567. Woods J.A; Davis J.M; Smith J.A; Nieman, D. C. (1999) “Exercise and Cellular Innate Immune Function.” Medical Science Sports Exercise, 31:1, 55-57. Perfect Health Made Simple, LeBeau, J. The PH Miracle: Balance Your Diet, Reclaim Your Health, Young, RO, Young S. Shinkai, S., Konishi, M., Shepard, R. J. (1998). “Aging and the Immune Response to Exercise.” Canadian Journal of Physiological Pharmacology, 76:5, 562-567. Basic Immunology, Sharon, J Alam, R. (1998). “A Brief Review of the Immune System” Primary Care, Dec, 25:4, 727-738. Cancer, 50 Essential Things To Do,
Anderson, G. The Cancer Cure That Worked, Lynes, B. Hess C; Steiger J.U; Schifferli J.A. (1998). "Compliment and its Role in Immune Response." Schweiz Med Worchenschr,128:11, 393-399. The Complete Cancer Survival Guide, Teeley, P; Bashe, P. Ember J.A., Hugli T.E. (1997). “Compliment Factors and Their Receptors.” Immunopharmacology, 38, 3-15. Woods J.A; Davis J.M; Smith J.A; Nieman, D. C. (1999) “Exercise and Cellular Innate Immune Function.” Medical Science Sports Exercise, 31:1, 55-57. Immunology, 4th Edition, Roitt, I., Brostoff, J., Male, D. Beilharz M.W; McDonald W; Watson M.W; Heng J; McGeachie J; Lawson C.M. (1997). "Low Dose Oral Type I Interferons Reduce Early Virus Replication of Murine Cytomegalovirus in Vivo.” J Interferon Cytokine Res, 17:10, 625-630. "Maximum-tolerated doses of ifosfamide, carboplatin and etoposide given over 6 days followed by autologus stem-cell rescue: toxicity profile." (1995). Fields, KK, et al. Journal of Clinical Oncology 13:323-332. Natural Strategies for Cancer Patients, Blaylock, R. MD. Tenover, F.C. (1996). “Reasons for the Emergence of Antibiotic Resistance.” American Journal of Medical Science 311(1), 9-16. What You Really Need to Know About Cancer, Buckman, R., Dr. Wintrobe’s Clinical Hematology, 10th edition, Paraskevas, F. "Cell Interactions in the Immune Response," 568-569. Papassotiropoulos A., Bagli M., Jessen F., et al. (1999). "A genetic variation of the inflammatory cytokine IL-6 delays the initial onset and reduces the risk for sporadic Alzheimer’s disease." Ann Neurol, 45:666-668. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the IL-6 gene onIL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102:1369-76. Samaniego F, Markham P, Gallo R, et al. Inflammatory cytokines induce AIDS-Kaposi’s sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi’s sarcoma-like lesion formation in nude mice. J Immunol 1995;154:3582-92. Foster C, Lehrnbecher T, Samuels S, et al. An IL-6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Blood 2000; 96:2562-7. Antman K, Chang Y. Kaposi’s sarcoma. N Engl J Med 2000; 342:1027-38. Klauke S, Schoefer H, Althoff P, et al. Sex hormones as a cofactor in the pathogenesis of epidemic Kaposi’s sarcoma. AIDS 1995; 9:1295-6. Dourado I. Interleukin 6 and AIDS-associated Kaposi’s sarcoma: a nested case control study within the Multicenter AIDS Cohort Study. AIDS Res Hum Retroviruses 1997;13:781-8. Neyts J, De Clerq E. Antiviral drug susceptibility of human herpes-virus 8. Antimicrob Agents Chemother 1997;41:2754-6. Alkalize or Die, Baroody, T. Loft, S., Poulsen, H. (1996) "Cancer Risk and Oxidative DNA Damage in Man." Journal of Molecular Medicine 74: 297-312 Cook Right For Your Type, D'Adamo, P.J. Eat Right For Your Type, D'Adamo, P.J. Enzyme Nutrition, Howell, Dr E. Flavonoids in Health and Disease, Rice-Evans, C.A., Packer, L. (editors)
Prasad, N.J., et al. (1999) "High Doses of Multiple Antioxidant Vitamins: Essential Ingredients in Imporving the Efficacy of Standard Cancer Therapy." Journal of American College of Nutrition 18: 13-25. Gapalakrisgna, R., Gudimeda, U., Chen, Z. (1995). "Nutrients in Cancer Prevention and Treatment" Humana, 21-37 Prasad K.N., Edwards-Prasad, J. (1992). "Vitamin E and Cancer Prevention: Recent Advances and Future Potentials" Journal of American College of Nutrition 11: 487-500. Evolution: A theory in Crisis, Denton, M. “In the Game of Energy and Thermodynamics You Can’t Even Break Even” Asmiov, I., Smithsonian, June 1970, P 10 Dawkins, R. (1982) “The Necessity of Darwinism." New Scientist Magazine 94:130 Not By Chance, Spetner, L. Vitamins, Supplements, Alternatives NOTICE: Eventually these will be put in alphabetical order. I am just beginning to go through my notes and what is listed here is only a portion of the research used. More will follow. I strongly urge anyone using this website to research what they are doing to the fullest extent possible. It is your life. and deserves the utmost attention you can give it. Anemarrhena, Phellodendron and Rehmannia F. (Zhi Bai Di Huang Wan): Yin Xu (Deficiency) (Hsu, 1980, p. 230; Yeung, p. 289; Dharmananda, 1986, p. 230; Bensky and Barolet, p. 265) Xiao Ji Yin Zi: Xue (Blood) Heat. (Yeung, p. 258; Bensky and Barolet, p. 341) Chih-ko and Curcuma C. (patent): All tumors (Dharmananda, 1990, p. 41) Zeng Ye Tang plus chrysanthemum flower (ju hua), trichosanthes root (tian hua fen), glehnia (sha shen), dioscorea (shan yao) and moutan bark (mu dan pi): Large Intestine Dryness: oral side-effects of radiation therapy: dryness that is worse at night, irritability, dry tongue, rapid thin pulse (Bensky and Barolet, p. 166) Dang Gui Ji Xue Teng Tang: Qi Xu (Deficiency) with Xue Xu (Blood Deficiency): leukopenia or thrombocytopenia during radiation therapy or chemotherapy (Bensky and Barolet, p. 251) Hoelen Five Herb Formula (Wu Ling San): side-effects of radiation (Hsu, 1980, p. 516; Yeung, p. 244; Dharmananda, 1986, p. 173; Bensky and Barolet, p. 174) Ji Xue Teng Qin Gao Pian (patent): increases white blood count . (Zhu, p. 103) Ci Wu Jia Pian (patent): Qi Xu (Deficiency) with Kidney Jing Xu (Essence Deficiency): enhances immune system, helps protect body from radiation; inhibits metastasis. (Zhu, p. 284) He Che Da Zao Wan (patent): Kidney Yin Xu (Deficiency) (Zhu, p. 286) Ling Zhi Feng Wang Jiang (patent): Qi Xu (Deficiency) with Xue Xu (Blood Deficiency) (Zhu, p. 262) Shark cartilage: 2 g per kg body weight, per day, to inhibit angiogenesis (growth of new blood vessels) in and to tumors. While anecdotal claims of efficacy are widespread no large scale, well-designed clinical research on the efficacy of cartilage for the treatment of cancer have been conducted so no conclusive evidence is available. (Lane, 1992) Vitamins C and E for patients using adriamycin: antioxidants, specifically reduces cardiac toxicity of adriamycin (Doxorubicin) (Fujita, et al., 1982, 42: p. 309-316; Ellison, 1985; 37 (3): 112-113; Am Heart J, 1986; 111: p. 95) » drug interactions: Vitamins B1, B2, B3, Vitamin K and folic acid can become deficient in patients using chemotherapy due to consequent anorexia, damage to the digestive tract, and malabsorption (Dreizen, et al., 1990; 87 (1): 163-170) Vitamin K has been found to potentiate various chemotherapeutic drugs in animals (Taper, et al., 1987; 40: 575-579) Vitamin A and cancer chemotherapy, esp. fluorouracil (5-FU): vitamin A enhances antitumor effect in animals (Nakagawa, et al., 1985; 76: 887-894) Ping Xiao Dan : Primary preventive and anticancer formula : (Jia Kun, p. 4, 13, 49) Gua Qi Dou Feng Wan: administered with Ping Xiao Dan for cough with a little sputum (Jia Kun, p. 49) Gua Qi Qian Jie Tang: administered with Ping Xiao Dan for mucus sputum ; administered with both Ping Xiao Dan and Gua Qi Dou Feng Wan for infection and purulent sputum with yellowish or deep-green color (Jia Kun, p. 49) Ai Feng Tang: administered with Ping Xiao Dan if purulent sputum, cough, SOB and thoracalgia (Jia Kun, p. 50) Suan Ai Tang: administered with Ping Xiao Dan if serious cough, hemoptysis and blood expectoration (Jia Kun, p. 50) Lan Feng Tang: fever and infection (Jia Kun, p. 50) Shen Qi Ai Ju Tang: if cough and shortness of breath become very serious (Jia Kun, p. 50) Dou Gong Wan: administered with Ping Xiao Dan when metastasis occurs and thoracalgia becomes sharp (Jia Kun, p. 50) Er Lian Ting Ling Tang: administered with Ping Xiao Dan for thoracic edema or acrocyanosis (Jia Kun, p. 50) Chih-ko and Curcuma C. (patent) plus Belamcanda 15 (patent): tumors (Dharmananda, 1990; Chih-ko and Curcuma, p. 41: Belamcanda, p. 64) Zeng Ye Tang plus chrysanthemum flower (ju hua), trichosanthes root (tian hua fen), glehnia (sha shen), dioscorea (shan yao) and moutan bark (mu dan pi): Large Intestine Dryness: oral side-effects of radiation therapy: dryness that is worse at night, irritability, dry tongue, rapid thin pulse (Bensky and Barolet, p. 166) Dang Gui Ji Xue Teng Tang: Qi Xu (Deficiency) with Xue Xu (Blood Deficiency): leukopenia or thrombocytopenia during radiation therapy or chemotherapy (Bensky and Barolet, p. 251) Hoelen Five Herbs F. (Wu Ling San) : side-effects from radiation. (Hsu, 1980, p. 516; Yeung, p. 244; Bensky and Barolet, p. 174) Ji Xue Teng Qin Gao Pian (patent): increases white blood count. (Zhu, p. 103) Ci Wu Jia Pian (patent): Qi Xu (Deficiency) with Kidney Jing Xu (Essence Deficiency): enhances immune system, helps protect body from radiation; inhibits metastasis. (Zhu, p. 284) Adenophora and Oldenlandia C . (Dharmananda, 1986, p. 479) He Che Da Zao Wan (patent): Kidney Yin Xu (Deficiency) (Zhu, p. 286) Ling Zhi Feng Wang Jiang (patent): Qi Xu (Deficiency) with Xue Xu (Blood Deficiency) (Zhu, p. 262) Yun Nan Bai Yao (patent): hemoptysis . (Zhu, p. 243) Yang Yin Qing Fei Tang Jiang (patent): chronic dry cough due to Yin Xu (Deficiency) (Zhu, p. 84) Xue Fu Zhu Yu Tang: Qi Stagnation with Xue Yu (Blood Stasis). (Yeung, p. 269; Bensky and Barolet, p. 314) Fritillaria and Wasp Nest F.; Dao Tan Tang: Phlegm. (Fritillaria: Dharmananda, p. 478; Dao Tan Tang: Yeung, p. 82 Bensky and Barolet, p. 448) Adenophora and Ophiopogon C. (Sha Shen Mai Men Dong Tang): Lung Yin Xu [No authors listed] AE 941--Neovastat. Drugs R D. 1999 Feb;1(2):135-136. [No authors listed] NCI to sponsor phase III trials of liquid shark cartilage angiogenesis inhibitor. Oncology (Huntingt). 1999 Jan;13(1):82. Berbari P, Thibodeau A, Germain L, Saint-Cyr M, Gaudreau P, El-Khouri S, Dupont E, Garrel DR. Antiangiogenic effects of the oral administration of liquid cartilage extract in humans. J Surg Res . 1999 Nov;87(1):108-113. Folkman J, Klagsburn M. Angiogenic factors. Science. 1987;235:442-447. Folkman J, Cotran R. Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol. 1976;16:207-248. (Review) Folkman J. The vascularization of tumors. Sci Am. 1976 May;234(5):58-64, 70-73. Langer R, Brem H, Falterman K, Klein M, Folkman J. Isolations of a cartilage factor that inhibits tumor neovascularization. Science. 1976 Jul 2;193(4247):70-72. Lee A, Langer R. Shark cartilage contains inhibitors of tumor angiogenesis. Science 1983 Sep 16;221(4616):1185-1187. Mathews J. Media feeds frenzy over shark cartilage as cancer treatment. J National Cancer Institute 1993 Aug 4;85(15):1190-1191. Mathews J. Sharks still intrigue cancer researchers. J National Cancer Institute 1992 July 1;84(13):1000-1002. McGuire TR, Kazakoff PW, Hoie EB, Fienhold MA. Antiproliferative activity of shark cartilage with and without tumor necrosis factor-alpha in human umbilical vein endothelium. Pharmacotherapy . 1996 Mar-Apr;16(2):237-244. Miller DR, Anderson GT, Stark JJ, Granick JL, Richardson D. Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer. J Clin Oncol 1998 Nov;16(11):3649-3655. 15;51(3):181-186. Ono M, Izumi H, Yoshida S, Goto D, Jimi S, Kawahara N, Shono T, Ushiro Kohno K, Sato Y, Kuwano M. Angiogenesis as a new target for cancer treatment. Cancer Chemother Pharmacol. 1996;38 Suppl:S78-82. (Review). Pauli BU, Memoli VA, Kuettner KE. Regulation of tumor invasion by cartilage-derived anti-invasion factor in vitro. J Natl Cancer Inst . 1981 Jul;67(1):65-73. Yamada Y, Nanba H, Kuroda H. Antitumor effect of orally administered body of Grifola frondosa (maitake). Chemotherapy 1990;38:790-796. Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS, Rothstein R, Summers RW, Snover DC, Beck GJ, Bond JH, Greenberg ER. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 1999 Jan 14;340(2):101-107. Nanba, H. Activity of Maitake D-fraction to Inhibit Carcinogenisis and Metastasis. Annals of the New York Academy of Sciences . September 30, 1995:243-245. Nanba, H, Antitumor activity of orally administered D-fraction from Maitake mushroom (Grifola frondosa). J Naturopathic Med . 1(4):10-15. Nanba, H, Hamaguchi, A, Kuroda, H. The chemical structure of an antitumor polysaccharide in fruit bodies of Grifola frondosa (maitake). Chem Pharm Bull 1987,35:1162-1168. Nanba, H. Immunostimulant activity in in-vivo and anti-HIV activity in vitro of 3 branched b-1-6-glucans extracted from maitake mushrooms (Grifola frondosa) Yamada, Y, Nanba, H, Kuroda, H. Antitumor effect of orally administered extracts from fruit body of Grifola frondosa (maitake). Chemotherapy 1990;38:790-796. General Cancer / Neoplasm (Research on Hoxey Formula) Avena sativa : nervous debility of convalescence (Felter, p. 235) Baptisia tinctoria : for tumorous or malignant conditions (Harper-Shove, p. 169) Berberis aquifolium : dyscrasiae due to cancerous cachexia (Felter and Lloyd, p. 348) Conium maculatum (toxic): pain of cancer (Felter and Lloyd, p. 594) Echinacea spp .: increases interferon production, purifies blood (Weiss, p. 326, Felter and Lloyd, p. 674) Gentiana lutea : bitter: promotes appetite, improves digestion in chronic debility (Felter, p. 390) Larrea divaricata : (Mexican folklore) Phytolacca decandra (toxic): carcinoma, adenoma; hard, swollen lymph nodes (Felter and Lloyd, p. 1474; Felter, p. 535) Rumex crispus : early stages of cancer; to prevent (Ellingwood, p. 379) Taraxacum officinale : loss of appetite, weak digestion (Felter and Lloyd, p. 1915) Trifolium pratense : alterative; purifies blood, cancerous diathesis; with daily use: patients are slower in developing carcinoma after excision (Felter and Lloyd, p. 1995, Felter, p. 682) Viola odorata : malignant disease, neoplasm in alimentary canal ; after tumor extirpation to protect from metastases . Combines well with Galium aparine (British Herbal Pharmacopoeia, p. 233) Viscum album (toxic): tumor-inhibiting effects reported, main use as follow-up therapy after surgery or radiation . Extracts available: Iscador (Weleda), Phenesol (Madaus), Helixior (Weiss, pp. 324, 325)
NOTICE: Under no circumstance is there any claim of any kind being made or implied that what I have chosen to do for myself has any merit to anyone other than me. This website or any printed matter I generate as a result of this website is not to be intended or in any way considered a substitute for the services of a medical professional. I am not to be considered in any way responsible for any consequences incurred by those who choose to employ the remedies or treatments I have reported. I make no claim that cancer is curable, least of all by me. I make no claim as to being able to prevent, diagnose, treat or cure any disease or infirmity of any type. It is strongly recommended and encouraged that everyone visiting this sight devote time to researching all possible treatment options that make sense to them and that they avail themselves of the expertise of those who are experienced in the treatment and “cure” of cancer; and that they seek whatever additional help and support their conditions warrant.
| |||||